OMEPRAZOLE, CYTOCHROME P450, AND CHEMICAL CARCINOGENESIS

被引：6
|
作者：
LUCIER, GW
THOMPSON, CL
HOEL, DG
机构：
来源：
GASTROENTEROLOGY | 1992年 / 102卷 / 05期
关键词：
D O I：
10.1016/0016-5085(92)91760-2
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
引用
收藏
页码：1823 / 1824
页数：2
相关论文
共 50 条
  • [1] Cytochrome P450 and chemical toxicology
    Guengerich, F. Peter
    CHEMICAL RESEARCH IN TOXICOLOGY, 2008, 21 (01) : 70 - 83
  • [2] Stereoselective metabolism of omeprazole by human cytochrome P450 enzymes
    Äbelö, A
    Andersson, TB
    Antonsson, M
    Naudot, AK
    Skånberg, I
    Weidolf, L
    DRUG METABOLISM AND DISPOSITION, 2000, 28 (08) : 966 - 972
  • [3] Evaluation of omeprazole and lansoprazole as inhibitors of cytochrome P450 isoforms
    Ko, JW
    Sukhova, N
    Thacker, D
    Chen, P
    Flockhart, DA
    DRUG METABOLISM AND DISPOSITION, 1997, 25 (07) : 853 - 862
  • [4] THE CYTOCHROMES P450 AND MECHANISMS OF CHEMICAL CARCINOGENESIS
    PARKE, DV
    ENVIRONMENTAL HEALTH PERSPECTIVES, 1994, 102 (10) : 852 - 853
  • [5] POSSIBLE SIMILAR ROLE OF CYTOCHROME P450 IN PRIMORDIAL EVOLUTION OF SPECIES AND IN CHEMICAL CARCINOGENESIS
    WICKRAMASINGHE, RH
    VILLEE, CA
    PERSPECTIVES IN BIOLOGY AND MEDICINE, 1976, 19 (04) : 473 - 475
  • [6] Cytochrome P450 and chemical toxicology.
    Guengerich, F. Peter
    CHEMICAL RESEARCH IN TOXICOLOGY, 2006, 19 (12) : 1679 - 1679
  • [7] Cytochrome P450 networks in chemical space
    Soyoung Lee
    Dongsup Kim
    Archives of Pharmacal Research, 2010, 33 : 1361 - 1374
  • [8] Cytochrome P450 Networks in Chemical Space
    Lee, Soyoung
    Kim, Dongsup
    ARCHIVES OF PHARMACAL RESEARCH, 2010, 33 (09) : 1361 - 1374
  • [9] The role of cytochrome P450 family members in breast carcinogenesis
    Singh, S.
    Alavi, H.
    Krstic-Demonacos, M.
    Demonacos, C.
    INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE, 2015, 36 : S109 - S109
  • [10] Evaluation of omeprazole and lansoprazole as inhibitors of cytochrome P450 isoforms.
    Ko, JW
    Sukhova, N
    Thacker, D
    Chen, P
    Flockhart, DA
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 1997, 61 (02) : PII23 - PII23
12345